荷兰卵巢癌集中化:诊断医院不再决定患者接受手术的概率
该研究基于荷兰癌症登记系统2000至2015年确诊的FIGO IIB-IV期上皮性卵巢癌患者,评估手术集中化前后诊断医院是否影响患者接受手术的可能性。多水平多因素逻辑回归显示,2000-2005年和2006-2011年诊断医院显著影响手术概率,但2012-2015年不再显著。
要点
- 2012年荷兰实施晚期上皮性卵巢癌手术集中化。
- 2000-2005年及2006-2011年诊断医院显著影响手术概率,2012-2015年不再显著。
核心结论
- 手术集中化解决了晚期上皮性卵巢癌患者接受细胞减灭术概率的医院间差异。
- 自2012年集中化建立后,决定是否手术似乎仅归因于患者和肿瘤特征。
研究设计与样本
- 从荷兰癌症登记系统选取2000至2015年确诊的FIGO IIB-IV期上皮性卵巢癌患者,共15,314例。
- 采用多水平多因素逻辑回归分析诊断医院与后续时期接受手术可能性之间的关联。
- 采用多变量Cox回归模型分析总生存变化。
主要发现
- 2000-2005年诊断医院是患者接受手术可能性的显著水平(LR检验p<0.001)。
- 2006-2011年诊断医院是患者接受手术可能性的显著水平(LR检验p=0.002)。
- 2012-2015年诊断医院不是患者接受手术可能性的显著水平(LR检验p=0.127)。
临床怎么用
- 原文结论未据此给出具体临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Surgical care for advanced stage epithelial ovarian cancer (EOC) patients has been centralized in the Netherlands since 2012. We evaluated whether the likelihood for patients to undergo surgery depends on the hospital of initial diagnosis before and after centralization of surgical care. METHODS: Patients with EOC FIGO stage IIB-IV, diagnosed in the Netherlands between 2000 and 2015, were identified from the Netherlands Cancer Registry. Multilevel multivariate logistic regression was used to study the association between hospital of diagnosis and patients' likelihood of undergoing surgery in subsequent time periods. Furthermore, changes in overall survival were analyzed by multivariable Cox regression models. RESULTS: 15,314 EOC patients were selected from the NCR. Hospital of diagnosis was identified as a significant level for patients' likelihood of undergoing surgery in 2000-2005 (LR test p<0.001), as well as in 2006-2011 (LR test p=0.002) but not in 2012-2015 (LR test p=0.127). Patients who underwent surgery in 2012-2015 had a better survival when compared to 2006-2011 (HR 0.90(0.84-0.96)). CONCLUSION: This study shows that centralization of surgical care resolved the variation between hospitals in the probability to undergo cytoreductive surgery for patients with advanced EOC. Since centralization was established in 2012, the decision to operate patients seems solely attributable to patient and tumor characteristics. This supports the growing evidence in favor of centralizing (surgical) treatment for complex and heterogeneous diseases such as EOC.
引用
- Timmermans M, Schuurman MS, Ho VKY, et al. Centralization of ovarian cancer in the Netherlands: Hospital of diagnosis no longer determines patients' probability of undergoing surgery. Gynecol Oncol. 2017. PMID: 29129391. doi:10.1016/j.ygyno.2017.11.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。